3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
6
Recruiting
2
Completed
2
Terminated
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
6
Melanoma
6
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Mouth Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Neoplasms
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Dysplasia
2
Skin Neoplasms
2
Sarcoma, Kaposi
2
Sarcoma
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Inflammatory Breast Neoplasms
2
HIV Infections
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Turcot syndrome
1
Thrombocytosis
1
Interventions
Cyclophosphamide
6
Isotretinoin
5
thymoglobulin
4
fludarabine phosphate
4
fludarabine
4
aldesleukin
4
Topotecan
4
Temozolomide
4
Melphalan
4
Irinotecan
4
Etoposide
4
ribociclib
3
Thiotepa
3
Interleukin-2
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Busulfan
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
temsirolimus
2
omburtamab I-131
2
dinutuximab
2
Vincristine
2
Tretinoin
2
TPI-287
2
Stem Cell Transplantation
2
Rituximab
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neuroblastoma
×
Biopsy
×
Clear all
NCT02780128
2026-03-10
NEPENTHE
Children's Hospital of Philadelphia
Phase 1
Terminated
66 enrolled